未登录
分享
收藏
分享
收藏Alectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort study阿来替尼对比克唑替尼作为ALK阳性晚期非小细胞肺癌患者的一线治疗:一项中国真实世界队列研究
Zhang, Haoran; Wu, Zhaozhen; Lu, Tao; Zhang, Hui; Li, Ji; Zhang, Dongming; Yu, Siyuan; Guo, Xiaobei; Feng, Xiaoyi; Liu, Jia; Shi, Yuequan; Gao, Xiaoxing; Liu, Xiaoyan; Chen, Minjiang; Zhao, Jing; Zhong, Wei; Hu, Ying; Xu, Yan; Wang, Mengzhao
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Corrigendum to Risk factors of lymph node metastasis in the diffuse sclerosing variant of papillary thyroid carcinoma compared with conventional papillary thyroid carcinoma in pediatric populations (vol 160 (2025) , artn 107120, 2025)
Liu, Yanan; Fu, Nantao; Liu, Haitao; Su, Shanshan; Yang, Tingting; Long, Ping; Zhong, Wei; Min, Xiang
分享
收藏
分享
收藏
分享
收藏
分享
收藏Alectinib versus crizotinib as first-line treatment in patients with advanced ALK-mutated non-small cell lung cancer: a Chinese, real-world cohort study
Zhang, Haoran; Wu, Zhaozhen; Zhang, Dongming; Liu, Jia; Lu, Tao; Shi, Yuequan; Gao, Xiaoxing; Liu, Xiaoyan; Feng, Xiaoyi; Guo, Xiaobei; Yu, Siyuan; Zhao, Jing; Chen, Minjiang; Zhong, Wei; Xu, Yan; Hu, Ying; Wang, Mengzhao
分享
收藏
分享
收藏
分享
收藏Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study
Zheng, Jing; Wang, Tao; Yang, Yunpeng; Huang, Jie; Feng, Jifeng; Zhuang, Wu; Chen, Jianhua; Zhao, Jun; Zhong, Wei; Zhao, Yanqiu; Zhang, Yiping; Song, Yong; Hu, Yi; Yu, Zhuang; Gong, Youling; Chen, Yuan; Ye, Feng; Zhang, Shucai; Cao, Lejie; Fan, Yun; Wu, Gang; Guo, Yubiao; Zhou, Chengzhi; Ma, Kewei; Fang, Jian; Feng, Weineng; Liu, Yunpeng; Zheng, Zhendong; Li, Gaofeng; Wang, Huijie; Cang, Shundong; Wu, Ning; Song, Wei; Liu, Xiaoqing; Zhao, Shijun; Ding, Lieming; Selvaggi, Giovanni; Wang, Yang; Xiao, Shanshan; Wang, Qian; Shen, Zhilin; Zhou, Jianya; Zhou, Jianying; Zhang, Li
分享
收藏
分享
收藏Single cell RNA-sequencing analysis reveals that N-acetylcysteine partially reverses hepatic immune dysfunction in biliary atresia单细胞RNA测序分析显示N-乙酰半胱氨酸部分逆转胆道闭锁的肝脏免疫功能障碍
Ye, Rongchen; Ma, Sige; Chen, Yan; Shan, Jiarou; Tan, Ledong; Su, Liang; Tong, Yanlu; Zhao, Ziyang; Chen, Hongjiao; Fu, Ming; Guo, Zhipeng; Zuo, Xiaoyu; Yu, Jiakang; Zhong, Wei; Zeng, Jixiao; Liu, Fei; Chai, Chenwei; Guan, Xisi; Wang, Zhe; Liu, Tao; Liang, Jiankun; Zhang, Yan; Shi, Hongguang; Wen, Zhe; Xia, Huimin; Zhang, Ruizhong
分享
收藏Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study
Zhang, Dongming; Liu, Xiaoyan; Shen, Fangfang; Zhao, Dahai; Shi, Yuequan; Zhang, Haoran; Liu, Jia; Gao, Xiaoxing; Chen, Minjiang; Zhao, Jing; Zhong, Wei; Gao, Junzhen; He, Min; Liu, Yonggang; Yang, Xiaoling; Qin, Jianwen; Tang, Yuling; Mu, Xinlin; Gu, Yangchun; Zhang, Shucai; Chen, Xueqin; Pang, Li; Meng, Qingwei; Guo, Ye; Zhang, Yuhui; Li, Wei; Xing, Puyuan; Cheng, Yuan; Xin, Tao; Li, Qingxia; Li, Yu; Chen, Jun; Gao, Feng; Jin, Bo; Rossi, Antonio; Adachi, Hiroyuki; Guerrera, Francesco; Husain, Hatim; Xu, Yan; Wang, Mengzhao
分享
收藏